BUPRENORPHINE HCL

Product NDC
76519-1170
11-digit product format
765191170
Labeler code
76519
Product ID
76519-1170_77d3c308-58b9-2ab0-e053-2991aa0a4918
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
BUPRENORPHINE HCL
Dosage form
TABLET
Route
SUBLINGUAL
Labeler
H.J. Harkins Company, Inc.
Application
ANDA078633
Marketing category
ANDA
Marketing start
2018-03-16
Marketing end
0000-00-00
Substance
BUPRENORPHINE HYDROCHLORIDE
Active strength
8 mg/1
Pharmacologic classes
Partial Opioid Agonists [MoA],Partial Opioid Agonist [EPC]
DEA schedule
CIII
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
68654759-f50b-79ef-24c5-544d94fe7d87Product name320251114
08a295bb-88df-4ab0-a120-a75a789a74f1Product name120231013
ab841ac7-728a-4fc9-be0a-35b96cecbf39Product name420230306
100316cc-94a9-474e-97ad-9b5c6ddec605Product name520230125
539bc5d3-546b-4af6-9c31-058ce6c459d3Product name220220210
b871fccd-1de6-4c7f-b9e5-045304641ee6Product name820220118
31e16ab2-c562-4617-a3e8-ed285320e16eProduct name120180201
4c23a34c-e8fc-424c-8fa0-ee064ba6eaefProduct name120170706
a5920611-4285-f024-69b9-39ff338b81eaProduct name520170609
3df867ed-9d48-45cf-bded-1394beaea0b1Product name320161206
973da5bf-b1f9-4de0-81ee-7ca066c98ca4Product name120160712

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76519-1170-0BUPRENORPHINE HCLSL14 in 1 BOTTLETABLET141
76519-1170-1BUPRENORPHINE HCLSL28 in 1 BOTTLETABLET281
76519-1170-2BUPRENORPHINE HCLSL56 in 1 BOTTLETABLET561
76519-1170-3BUPRENORPHINE HCLSL70 in 1 BOTTLETABLET701
76519-1170-4BUPRENORPHINE HCLSL84 in 1 BOTTLETABLET841
76519-1170-5BUPRENORPHINE HCLSL42 in 1 BOTTLETABLET421

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76519-1170BUPRENORPHINE HCL SL (BUPRENORPHINE HCL) TABLET [H.J. HARKINS COMPANY, INC.]1Legacy NDC, 6 package rows20181024_77d3c308-58b8-2ab0-e053-2991aa0a4918.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
351265buprenorphine HCl 8 MG Sublingual TabletPSN77d3c308-58b8-2ab0-e053-2991aa0a49181
351265buprenorphine 8 MG Sublingual TabletSCD77d3c308-58b8-2ab0-e053-2991aa0a49181
351265buprenorphine 8 MG (as buprenorphine HCl 8.64 MG) Sublingual TabletSY77d3c308-58b8-2ab0-e053-2991aa0a49181

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
76519-1170-07651911700014 in 1 BOTTLEHistorical
76519-1170-17651911700128 in 1 BOTTLEHistorical
76519-1170-27651911700256 in 1 BOTTLEHistorical
76519-1170-37651911700370 in 1 BOTTLEHistorical
76519-1170-47651911700484 in 1 BOTTLEHistorical
76519-1170-57651911700542 in 1 BOTTLEHistorical